Business Context and Reporting Period
This Form 8-K Current Report was filed by Healthcare Trust of America, Inc. (NYSE: HTA) and its operating partnership, Healthcare Trust of America Holdings, LP, on September 28, 2020. The filing reports the entry into a material definitive agreement regarding a new public debt offering.
Key Financial Metrics and Transaction Details
The Company issued $800 million in aggregate principal amount of 2.000% Senior Notes due 2031 (the "2031 Notes").
- Principal Amount: $800 million
- Interest Rate: 2.000% per year, payable semi-annually in arrears beginning March 15, 2021.
- Maturity Date: March 15, 2031.
- Offering Price: 99.196% of principal amount.
- Security Status: General unsecured and unsubordinated obligations, ranking equally with existing senior notes (due 2023, 2026, 2027, and 2030) and senior to subordinated indebtedness.
- Guarantees: Fully and unconditionally guaranteed by Healthcare Trust of America, Inc.
Material Changes and Debt Structure
The issuance of the 2031 Notes increases the Company's total senior unsecured indebtedness. The notes are structurally subordinated to all liabilities of the Operating Partnership's subsidiaries and effectively subordinated to secured indebtedness to the extent of the collateral value. The filing does not provide specific comparative financial metrics (revenue, profit, cash flow) for the period, as this report focuses solely on the debt transaction.
Terms, Covenants, and Risks
Redemption Terms: The notes are redeemable at the Company's option prior to December 15, 2030, at a price equal to the greater of 100% of the principal or the present value of remaining payments plus 25 basis points. On or after December 15, 2030, they are redeemable at 100% of principal plus accrued interest.
Covenants: The indenture includes limitations on incurring additional indebtedness, requirements to maintain a pool of unencumbered assets, and insurance requirements.
Events of Default: Include failure to pay interest for 90 days, failure to pay principal, failure to comply with covenants (with a 90-day cure period), failure to pay other indebtedness exceeding $50 million (or $35 million while certain older notes are outstanding), and bankruptcy or insolvency events.
Investor Verification Checklist
- Verify the net proceeds from the offering after deducting underwriting discounts and expenses.
- Confirm the specific use of proceeds as disclosed in the accompanying prospectus or press release.
- Review the updated leverage ratios and debt maturity schedule following the $800 million issuance.
- Assess the impact of the 2.000% coupon rate on future interest expense relative to existing debt.
- Examine the "unencumbered assets" covenant requirements to ensure compliance with the new indenture.